Literature DB >> 2735928

Neurosteroids: steroidogenesis in primary cultures of rat glial cells after release of aminoglutethimide blockade.

Z Y Hu1, I Jung-Testas, P Robel, E E Baulieu.   

Abstract

Newborn rat glial cells were established in primary culture for greater than or equal to 3 weeks under conditions previously reported to permit differentiation of cholesterol side-chain cleavage activity. The cells were incubated for 48h with 3-H-Mevalonolactone in presence of Mevinolin (avoiding isotopic dilution of endogenous origin) and aminoglutethimide, a blocker of cholesterol side-chain cleavage. Radioactive steroid synthesis was then allowed to proceed in absence of aminoglutethimide, for 16h in presence of Trilostane, an inhibitor of 3 beta-hydroxysteroid dehydrogenase precluding formation of delta 4-3-ketosteroids. 3H-cholesterol accounted for approximately 10 percent of the radioactivity in cell extracts. 3H-delta 5-pregnene-3 beta, 20 alpha-diol (20-OH P) was the major steroid produced and was released in the culture medium. Dexamethasone (10 nM) increased 20-OH P formation by 30 percent, whereas cellular 3H-cholesterol decreased more than expected from the augmented formation of 20-OH P.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2735928     DOI: 10.1016/0006-291x(89)92686-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Age-related changes in peripheral benzodiazepine receptors of human platelets.

Authors:  D Marazziti; M L Pancioli-Guadagnucci; A Rotondo; G Giannaccini; C Martini; A Lucacchini; G B Cassano
Journal:  J Psychiatry Neurosci       Date:  1994-03       Impact factor: 6.186

2.  Changes in peripheral benzodiazepine receptors in patients with bipolar disorder.

Authors:  Donatella Marazziti; Bernardo Dell'Osso; Stefano Baroni; Irene Masala; Elena Di Nasso; Gino Giannaccini; Liliana Dell'Osso
Journal:  Neuropsychiatr Dis Treat       Date:  2005-06       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.